Kendle Expands Asia/Pac Operations

Kendle has opened a second office in western India in Ahmedabad, expanding its presence in the country. Kendle has operated in New Delhi since 2004 and is planning additional expansion in India in 2009.

“Expansion in the Asia/Pacific region, and India in particular, is essential to our continued success as a top global CRO,” said Candace Kendle, Pharm.D., chairman and chief executive officer. “Our increased presence and capacity in the region will allow us to better meet the needs of our customers who are seeking to capitalize on India’s cost-effective, yet high-quality clinical research capabilities to develop their compounds. Our expansion into Ahmedabad is another step in our continued development of a best-in-class infrastructure throughout Asia.”

Kendle’s India operations provide early and late stage clinical development services for all phases of trials across all therapeutic areas. The new Ahmedabad office offers increased efficiencies and geographic coverage and provides access to the western part of the country. Some analysts estimate that by 2011 as many as 15% of all global trials will be conducted in India.